Disability Case Manager: Full Member of the Revalidation Team
1 other identifier
interventional
80
1 country
2
Brief Summary
The first 4-6 months after an incident which caused a handicap or chronic disease, it is important to involve and motivate patients to return to work. After this period, there is a major decrease on successful vocational reintegration. To facilitate vocational rehabilitation a Disability Case Manager (DCM) may play a major role. The DCM will act as key figure between the patient, the multidisciplinary team of the revalidation centre, the employers and other back-to-work services. There is need to provide evidence on the value of this program. The aim of this study is to test the added value of including a DCM in the classic revalidation trajectory, who will focus on early vocational and/or social rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 4, 2019
CompletedFirst Posted
Study publicly available on registry
June 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedJanuary 22, 2021
January 1, 2021
3.3 years
June 4, 2019
January 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in Quality of Life: Short Form 36 questionnaire
Short Form 36 questionnaire. This questionnaire includes 11 questions with different scale ranges and contents.
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Change in mental functioning: depressive feelings, anxiety and stress
Depression, Anxiety and Stress scale 21 questionnaire. Scale ranges from 0 to 3 (0 = never applicable, 1 = sometimes applicable, 2 = often applicable, 3 = certainly applicable). The lower values represent a better outcome.
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Change in functional status
Barthel Activities of Daily Living (ADL) index. Scale ranges from 0 to 2 or 3, each topic (feeding, bathing, grooming, dressing, bowels, bladder, toilet use, transfers (bed to chair and back), mobility and stairs) has its own scale content. The higher values represent a better outcome.
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Change in participation
Nottingham ADL index. Scale ranges from 0 to 3 (0 = patient can not execute the activity, 1 = patient can execute the activity with help, 2 = patient can execute the activity, but it is still difficult, 3 = patient can execute the activity easily). The higher values represent a better outcome.
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Change in work status (questionnaire)
Follow up of current working status. Scales ranges from 0 to 7 (0 = no work, 1 = retirement, 2 = volunteer work, 3 = still in support of re-employment, 4 = half time other work, 5 = other work, 6 = half time same work, 7 = same work)
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Secondary Outcomes (6)
Change in coping
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Change in self-effectiveness
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Expectations concerning back-to-work
pre (at moment of inclusion)
Change in satisfaction with revalidation traject
post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
Change in expectations concerning back-to-work
pre (at moment of inclusion), post (at the end of the revalidation period, on average after 6 months) and follow-up (6 months after revalidation)
- +1 more secondary outcomes
Study Arms (2)
Jessa Hospital, Herk-de-Stad
EXPERIMENTAL"Back to Work" methodology: a revalidation trajectory with standard revalidation therapy in combination with an early focus on "back to work", using a "Disability Case Manager"
Revalidation and MS Clinic Overpelt
NO INTERVENTIONStandard revalidation therapy without explicit focus on "back to work"
Interventions
The DCM will act as key figure between the patient, the multidisciplinary team of the revalidation centre, the employers and other back-to-work services in order to increase vocational reintegration after an incident which caused a handicap or chronic disease.
Eligibility Criteria
You may qualify if:
- Complex neuro-motoric conditions
- Age between 18-62 year
- Working
- Persons belonging to the National Institute for Health and Disability Insurance (NIHDI) target group
You may not qualify if:
- Comatose patients
- Retired patients
- Students
- Persons who not belong to the NIHDI target group
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- PXL University Collegelead
- Jessa Hospitalcollaborator
- Revalidatie & MS Centrum Overpeltcollaborator
- RIZIVcollaborator
Study Sites (2)
Jessa Hospital, Campus Sint-Ursula
Hasselt, Limburg, 3500, Belgium
Revalidation & MS Clinic Overpelt
Overpelt, Limburg, 3900, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Annemie Spooren, PhD
PXL University College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2019
First Posted
June 25, 2019
Study Start
March 1, 2017
Primary Completion
June 30, 2020
Study Completion
September 30, 2020
Last Updated
January 22, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share